Safety of Arthritis Drugs, Day 2, Part 4
The Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2”…
344 viewsThe Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2”…
344 viewsPhysicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues including initial…
130 viewsPhysicians spoke at a meeting to assess the safety records of arthritis drugs such as Vioxx and Celebrex. They also talked about recent uses of the class of drugs, the medical and scientific basis for the…
73 viewsPhysicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drugs Celebrex, Bextra, Parecoxib, and Naproxen spoke as did representatives for the Food and Drug…
252 views